Stockreport

Evan Ballantyne to join Hansa Biopharma as Chief Financial Officer [Yahoo! Finance]

Gain Therapeutics, Inc.  (GANX) 
PDF Chief Financial Officer (CFO), effective 1 March 2024 . He succeeds Donato Spota , who, as previously announced, will leave the Company on 28 February. As CFO, Mr. Bal [Read more]